US 11382922
Aqueous oral pharmaceutical suspension compositions
granted A61KA61K31/573A61K47/02
Quick answer
US patent 11382922 (Aqueous oral pharmaceutical suspension compositions) held by ReveraGen BioPharma, Inc. expires Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ReveraGen BioPharma, Inc.
- Grant date
- Tue Jul 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/573, A61K47/02, A61K47/10, A61K47/12